UNITY Biotechnology

About:

Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging.

Website: http://unitybiotechnology.com

Twitter/X: unitybiotech

Top Investors: Hercules Capital, Fidelity, ARCH Venture Partners, Founders Fund, Invus

Description:

Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.

Total Funding Amount:

$295M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)unitybiotechnology.com

Founders:

Keith Leonard, Nathaniel David

Number of Employees:

11-50

Last Funding Date:

2023-11-10

IPO Status:

Public

Industries:

© 2025 bioDAO.ai